From: Phlebovirus seroprevalence in Austrian Army personnel returning from missions abroad
Titer ≥ 1:10 | Titer ≥ 1:20 | Titer ≥ 1:100 | ||||
---|---|---|---|---|---|---|
IgG positive/Total (%) | OR/95% CI (P-value) | IgG positive/Total (%) | OR/95% CI (P-value) | IgG positive/Total (%) | OR/95% CI (P-value) | |
Soldiers before missions | 31/267 (11.6) | Reference | 23/267 (8.6%) | Reference | 12/267 (4.5) | Reference |
BIH | 7/61 (11.5) | 1.0/0.4–2.5 (1.0) | 7/61 (11.5%) | 1.4/0.5–3.5 (0.46) | 3/61 (4.9) | 1.1/0.2–4.3 (1.0) |
Kosovo | 54/261 (20.7) | 1.9/1.2–3.2 (0.006)* | 31/261 (11.9%) | 1.5/0.8–2.7 (0.25) | 14/261 (5.4) | 1.2/0.5–2.9 (0.70) |
Syria | 18/101 (17.8) | 1.7/0.8–3.2 (0.12) | 15/101 (14.9%) | 2.0/0.9–4.3 (0.05)* | 8/101 (7.9) | 1.8/0.6–5.0 (0.20) |
Lebanon | 9/63 (14.3) | 1.3/0.5–3.0 (0.50) | 8/63 (12.7) | 1.7/0.6–4.2 (0.22) | 6/63 (9.5) | 2.23/0.7–6.8 (0.13) |